Genomic Study of LDL Receptor Gene Deletions in Danish Patients
Author Information
Author(s): Peter H. Nissen, Dorte Damgaard, Anette Stenderup, Gitte G. Nielsen, Mogens L. Larsen, Ole Færgeman
Primary Institution: Aarhus University Hospital, Aarhus, Denmark
Hypothesis
The study aims to characterize five deletions in the LDL receptor gene in Danish Familial Hypercholesterolemic subjects.
Conclusion
The identification of the breakpoints should enable the development of specific tests for these mutations and supports the role of Alu repeats in intragenic deletions.
Supporting Evidence
- Five deletions in the LDLR gene were identified in Danish patients with Familial Hypercholesterolemia.
- The study provides evidence that Alu repeats are involved in the mechanism of these deletions.
- A diagnostic assay was developed to detect the exon 7-8 deletion in affected individuals.
Takeaway
The researchers looked at five specific changes in a gene that helps control cholesterol levels in the blood, which can cause heart problems if not working right.
Methodology
The study characterized deletions by amplifying mutated alleles and sequencing to identify genomic breakpoints, and developed a diagnostic assay using duplex PCR.
Limitations
The MLPA method used does not include the promoter, exon 10, or exon 13 of the LDLR gene, which may lead to undiagnosed mutations in these regions.
Participant Demographics
Danish patients with Familial Hypercholesterolemia.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website